EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating metabolic syndrome markers and body mass index changes in patients with acne vulgaris treated with isotretinoin: A prospective study

Afsaneh Sadeghzadeh Bazargan iD, Alireza Jafarzadeh iD, Fatemeh Danandeh, Sepideh Salehi

Journal of Cosmetic Dermatology · 2024-12 · 23 (12) · 4343-4348

DOI: 10.1111/jocd.16533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 14.08.2024. Verfasst von Afsaneh Sadeghzadeh Bazargan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical …. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Dermatologic Agents, Body Mass Index. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acne vulgaris is a common inflammatory skin disease that occurs during puberty, affecting approximately 85% of young adults and may persist into adulthood. The pathophysiology of acne is multifactorial, involving hormonal, inflammatory, and immune mechanisms. Isotretinoin is widely used for treating severe cystic acne or recurrent acne. This medication is considered a pharmacological option that significantly reduces sebum secretion, leading to a reduction in the size of sebaceous glands. It also induces a lack of differentiation in sebaceous cysts, resulting in a decrease in lipid accumulation.

Method

This research is a prospective study. Patient contact details were obtained directly from those visiting the dermatology clinic, and they were monitored for a duration of 3 months. Essential data was gathered through patient examinations and inquiries at the clinic, including the prescription of tests prior to initiating isotretinoin treatment. Furthermore, follow‐up tests and examinations were performed within the initial and third months post‐treatment commencement.

Results

Sixty‐two patients participated in the study, selected through non‐probability (convenience) sampling. The therapeutic dose taken by patients was 20 mg of isotretinoin daily ( n = 49) or every other day ( n = 13). Among the participants, six patients experienced a decrease of 3 units or more in HDL levels, while 16 patients saw an increase of 3 units or more in LDL levels, 3 months after beginning the treatment. Additionally, the triglyceride (TG) levels increased by 9 units or more in six individuals, and the blood sugar (BS) levels increased by 5 units or more in nine individuals, 3 months after treatment initiation. Moreover, one person's waist circumference increased by 1.5 cm 3 months after treatment began. The average weight of the individuals at the end of the treatment rose from 60.74 kg to 61.12 kg. However, this weight increase was not statistically significant. ( p > 0.05).

Conclusion

In general, the results of our study show that the use of oral isotretinoin as a treatment option for the management of acne vulgaris can be effective when administered at the correct dosage, offering a safe and low‐complication option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinAcne VulgarisDermatologic AgentsBody Mass IndexMetabolic SyndromeHumansProspective StudiesFemaleMaleYoung AdultAdultAdolescentBiomarkersTriglyceridesCholesterol, HDL

Stichwörter der Autor:innen

BMIIsotretinoinacnebody mass indexmetabolic syndrome

Substanzen

IsotretinoinDermatologic AgentsBiomarkersTriglyceridesCholesterol, HDL

Autor:innen und Institutionen

  • Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Faculty of Medicine, Iran university of Medical Sciences, Tehran, Iran.
  • Department of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Afsaneh Sadeghzadeh Bazargan, Alireza Jafarzadeh

Zitieren

APA

Bazargan, A. S., Jafarzadeh, A., Danandeh, F., & Salehi, S. (2024). Investigating metabolic syndrome markers and body mass index changes in patients with acne vulgaris treated with isotretinoin: A prospective study. Journal of Cosmetic Dermatology, 23(12), 4343-4348. https://doi.org/10.1111/jocd.16533

Vancouver

Bazargan AS, Jafarzadeh A, Danandeh F, Salehi S. Investigating metabolic syndrome markers and body mass index changes in patients with acne vulgaris treated with isotretinoin: A prospective study. Journal of Cosmetic Dermatology. 2024;23(12):4343-4348. doi:10.1111/jocd.16533

BibTeX
@article{Bazargan2024,
  author = {Bazargan, Afsaneh Sadeghzadeh and Jafarzadeh, Alireza and Danandeh, Fatemeh and Salehi, Sepideh},
  title = {Investigating metabolic syndrome markers and body mass index changes in patients with acne vulgaris treated with isotretinoin: A prospective study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  volume = {23},
  number = {12},
  pages = {4343--4348},
  doi = {10.1111/jocd.16533}
}
Kostenlos starten →